Kircik L, Gold L, Gold M, Weiss J, Harper J, Del Rosso J
Dermatol Ther (Heidelb). 2024; 14(5):1211-1227.
PMID: 38724841
PMC: 11116301.
DOI: 10.1007/s13555-024-01155-7.
Touitou E, Natsheh H
Pharmaceutics. 2021; 13(12).
PMID: 34959410
PMC: 8706871.
DOI: 10.3390/pharmaceutics13122129.
Sharma S, Mathur D, Paliwal V, Bhargava P
J Clin Aesthet Dermatol. 2019; 12(5):34-38.
PMID: 31320975
PMC: 6561710.
Gerlach N, Graf R, Witte G, Lefort M, Pfluecker F, Heinrich U
Clin Cosmet Investig Dermatol. 2012; 5:101-9.
PMID: 22956882
PMC: 3430093.
DOI: 10.2147/CCID.S32669.
Schmidt N, Gans E
J Clin Aesthet Dermatol. 2011; 4(11):22-9.
PMID: 22125655
PMC: 3225141.
Acne vulgaris treatment : the current scenario.
Rathi S
Indian J Dermatol. 2011; 56(1):7-13.
PMID: 21572783
PMC: 3088940.
DOI: 10.4103/0019-5154.77543.
Lipid mediators in acne.
Ottaviani M, Camera E, Picardo M
Mediators Inflamm. 2010; 2010.
PMID: 20871834
PMC: 2943135.
DOI: 10.1155/2010/858176.
Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris.
Abd El All H, Shoukry N, El Maged R, Ayada M
Diagn Pathol. 2007; 2:4.
PMID: 17263887
PMC: 1797156.
DOI: 10.1186/1746-1596-2-4.
Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations.
Adly M, Adley M, Assaf H, Hussein M
J Clin Pathol. 2005; 58(12):1278-82.
PMID: 16311347
PMC: 1770800.
DOI: 10.1136/jcp.2005.027383.
Current concepts of the pathogenesis of acne: implications for drug treatment.
Gollnick H
Drugs. 2003; 63(15):1579-96.
PMID: 12887264
DOI: 10.2165/00003495-200363150-00005.
Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
Vogt K, Hermann J, Blume U, Gollnick H, Hahn H, Haustein U
Eur J Clin Microbiol Infect Dis. 1992; 11(10):943-5.
PMID: 1486893
DOI: 10.1007/BF01962381.
